Filing Flows › Utah Medical Products (UTMD) › Q1 2026
Utah Medical Products (UTMD) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 12, 2026
Utah Medical Products (UTMD) reported revenue of $8.7M for the first quarter 2026 (Q1 2026), -10% from a year earlier and -4% from the quarter before. Operating margin was 29.4%, net earnings $2.6M (29.9% of revenue).
Utah Medical Products, Q1 2026: revenue $8.7M (-10% year over year), operating margin 29.4%, net earnings $2.6M, operating cash flow $3.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.7M | -4% | -10% |
| Gross profit | $5.3M | +0.3% | -5% |
| Operating profit | $2.6M | +5% | -19% |
| Net earnings | $2.6M | +2% | -14% |
| Operating cash flow | $3.1M | -11% | -30% |
| Free cash flow | $3.0M | -12% | -30% |
What changed
Revenue was $8.7M in Q1 2026, down 10% year over year and down 4% from the previous quarter. Gynecology/Electrosurgery/Urology was the largest line at 60% of revenue.
Gross margin was 60.6%, up 3.5 points from Q1 2025. Operating profit was $2.6M, a 29.4% margin (down 3.1 points year over year). Operating expenses grew 14% against a revenue fall of 10%. The fastest-growing cost line was SG&A (+15%). Net earnings were $2.6M, down 14% year over year. The effective tax rate was 18.2%.
Operating cash flow was $3.1M (down 30% year over year), 119% of net earnings. Non-cash charges added back $673K of depreciation and amortization and $120K of share-based compensation. Working capital and other items used $288K. Capital expenditures of $130K left free cash flow of $3.0M.
Questions
What was Utah Medical Products' revenue in the first quarter 2026?
Utah Medical Products (UTMD) reported revenue of $8.7M for the first quarter 2026 (Q1 2026), -10% from a year earlier and -4% from the quarter before.
Was Utah Medical Products profitable in the first quarter 2026?
Operating profit was $2.6M (29.4% of revenue) and net earnings $2.6M.